Cargando…

A Novel Gene Signature Associated with Inflammatory Responses and Immune Status Assists in Prognosis and Intervention for Patients with HCC

BACKGROUND: Tumor growth depends on tumor cells and the tumor microenvironment, which are regulated by inflammation and immune responses. However, the roles of inflammation and immune status in hepatocellular carcinoma (HCC) remain unclear. The aim of this study was to evaluate the prognostic value...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Guofang, Du, Rui, Feng, Bin, Wang, Jianlin, Zhang, Fengrui, Pei, Jianming, Wang, Yuanyong, Shang, Yulong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759026/ https://www.ncbi.nlm.nih.gov/pubmed/36536645 http://dx.doi.org/10.2147/JIR.S390113

Ejemplares similares

An Inflammatory Response-Related Gene Signature Can Predict the Prognosis and Impact the Immune Status of Lung Adenocarcinoma
por: Shi, Yubo, et al.
Publicado: (2022)

Rho GTPase-activating protein 35 suppresses gastric cancer metastasis by regulating cytoskeleton reorganization and epithelial-to-mesenchymal transition
por: Sun, Yi, et al.
Publicado: (2022)

Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
por: Peng, Hong, et al.
Publicado: (2023)

Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation
por: Zhang, Rui-kun, et al.
Publicado: (2021)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC
por: Wang, Dong, et al.
Publicado: (2019)

A novel signature based on microvascular invasion predicts the recurrence of HCC
por: Du, Binbin, et al.
Publicado: (2020)

An Overview of Biomarkers and Molecular Signatures in HCC
por: Yim, Seon-Hee, et al.
Publicado: (2010)

The Association of HMGB1 Gene with the Prognosis of HCC
por: Xiao, Jianbiao, et al.
Publicado: (2014)

Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients
por: Jiang, Bei-Ge, et al.
Publicado: (2017)

M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC
por: Li, Rui, et al.
Publicado: (2023)

Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
por: Wei, Yulong, et al.
Publicado: (2021)

A Novel TNFSF-Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower-Grade Glioma
por: Tao, Rui, et al.
Publicado: (2022)

Inflammatory Mechanisms of HCC Development
por: Refolo, Maria Grazia, et al.
Publicado: (2020)

Elevated Serum Uric Acid is Associated With Poor Survival in Advanced HCC Patients and Febuxostat Improves Prognosis in HCC Rats
por: Wu, Le, et al.
Publicado: (2021)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC
por: Wang, Dong, et al.
Publicado: (2020)

Identification of HCC Subtypes With Different Prognosis and Metabolic Patterns Based on Mitophagy
por: Wang, Yao, et al.
Publicado: (2021)

Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Is a Promising Signature to Predict Prognosis and Therapies for Hepatocellular Carcinoma (HCC)
por: Chen, Yuyan, et al.
Publicado: (2023)

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
por: Shu, Jianfeng, et al.
Publicado: (2023)

A novel HCC prognosis predictor PDSS1 affects the cell cycle through the STAT3 signaling pathway in HCC
por: Rao, Zuqin, et al.
Publicado: (2022)

Using cell-free DNA for HCC surveillance and prognosis
por: Tran, Nguyen H., et al.
Publicado: (2021)

Retraction: The Association of HMGB1 Gene with the Prognosis of HCC
Publicado: (2023)

A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment
por: Song, Binyu, et al.
Publicado: (2022)

Identification of Inflammatory Response-Related Gene Signature Associated With Immune Status and Prognosis of Lung Adenocarcinoma
por: Zou, Weijie, et al.
Publicado: (2021)

Characterization of 5-inflammatory-gene signature to affect the immune status and predict prognosis in breast cancer
por: Zang, Hongyan, et al.
Publicado: (2022)

Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery
por: Yang, Xiao-Yu, et al.
Publicado: (2018)

Prognosis Risk Model Based on Necroptosis-Related Signature for Bladder Cancer
por: Chen, Zhenghao, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy
por: Wang, Xiang-Xu, et al.
Publicado: (2022)

KIF14 and KIF23 Promote Cell Proliferation and Chemoresistance in HCC Cells, and Predict Worse Prognosis of Patients with HCC
por: Cheng, Chunxia, et al.
Publicado: (2020)

A Novel Ferroptosis-Related Gene Signature to Predict Prognosis of Esophageal Carcinoma
por: Wang, Jian, et al.
Publicado: (2022)

Identification of Prognosis-Related Oxidative Stress Model with Immunosuppression in HCC
por: Ren, Zhixuan, et al.
Publicado: (2023)

Improvement in prediction of prostate cancer prognosis with somatic mutational signatures
por: Zhang, Shengping, et al.
Publicado: (2017)

Deep View of HCC Gene Expression Signatures and Their Comparison with Other Cancers
por: Qian, Yuquan, et al.
Publicado: (2022)

Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence
por: Devan, Aswathy R., et al.
Publicado: (2023)

Status of, and strategies for improving, adherence to HCC screening and surveillance
por: Francica, Giampiero, et al.
Publicado: (2019)

An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma
por: Lin, Zhuo, et al.
Publicado: (2021)

A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer
por: Zhao, Ruijun, et al.
Publicado: (2022)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
por: Huang, Yan, et al.
Publicado: (2022)

A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma
por: Zhai, Wen-Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_irrapsiv6cjggrg1f8p4jmn6e1